Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schellekens

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Nature|December 17, 1987
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoitesL Schofield, J Villaquiran, A Ferreira, et al.
Arzneimittel-Forschung|August 1, 1971
Etomidate, R-(+)-ethyl-1-( -methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in ratsP A Janssen, C J Niemegeers, K H Schellekens, et al.
Journal of Occupational Rehabilitation|March 31, 2010
Measuring clients' perception of functional limitations using the Perceived Functioning & Health questionnaireJ M H Schellekens, F I Abma, H P G Mulders, et al.
Arzneimittel-Forschung|January 1, 1976
Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogsC J Niemegeers, K H Schellekens, W F Van Bever, et al.
Journal of Occupational Rehabilitation|September 17, 2002
Concurrent validity of questionnaire and performance-based disability measurements in patients with chronic nonspecific low back painMichiel F Reneman, Wim Jorritsma, Jan M H Schellekens, et al.
Cancer Treatment Reports|March 1, 1986
Growth inhibition and eicosanoid metabolism in the R3230AC mammary adenocarcinoma by interferonR A Karmali, H Schellekens, F Lefevre, et al.
Methods in Enzymology|January 1, 1986
Cloning, expression, and purification of rat IFN-alpha 1P H van der Meide, R Dijkema, M Caspers, et al.
Arzneimittel-Forschung|January 1, 1976
N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety marginW F Van Bever, C J Niemegeers, K H Schellekens, et al.
Transplantation Proceedings|August 1, 1987
Leukocyte binding and Ia-expression in vascular endotheliumP Häyry, D Leszczynski, T Paavonen, et al.
The Journal of Experimental Medicine|November 1, 1986
Antagonistic effects of gamma interferon and steroids on tissue antigenicityD Leszczynski, B Ferry, H Schellekens, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Nature|December 17, 1987
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoitesL Schofield, J Villaquiran, A Ferreira, et al.
Arzneimittel-Forschung|August 1, 1971
Etomidate, R-(+)-ethyl-1-( -methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in ratsP A Janssen, C J Niemegeers, K H Schellekens, et al.
Journal of Occupational Rehabilitation|March 31, 2010
Measuring clients' perception of functional limitations using the Perceived Functioning & Health questionnaireJ M H Schellekens, F I Abma, H P G Mulders, et al.
Arzneimittel-Forschung|January 1, 1976
Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogsC J Niemegeers, K H Schellekens, W F Van Bever, et al.
Journal of Occupational Rehabilitation|September 17, 2002
Concurrent validity of questionnaire and performance-based disability measurements in patients with chronic nonspecific low back painMichiel F Reneman, Wim Jorritsma, Jan M H Schellekens, et al.
Cancer Treatment Reports|March 1, 1986
Growth inhibition and eicosanoid metabolism in the R3230AC mammary adenocarcinoma by interferonR A Karmali, H Schellekens, F Lefevre, et al.
Methods in Enzymology|January 1, 1986
Cloning, expression, and purification of rat IFN-alpha 1P H van der Meide, R Dijkema, M Caspers, et al.
Arzneimittel-Forschung|January 1, 1976
N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety marginW F Van Bever, C J Niemegeers, K H Schellekens, et al.
Transplantation Proceedings|August 1, 1987
Leukocyte binding and Ia-expression in vascular endotheliumP Häyry, D Leszczynski, T Paavonen, et al.
The Journal of Experimental Medicine|November 1, 1986
Antagonistic effects of gamma interferon and steroids on tissue antigenicityD Leszczynski, B Ferry, H Schellekens, et al.
Pageof 16